Mayo Clinic is a nationally recognized center of expertise in diagnosing and treating all types of Hodgkin's lymphoma and non-Hodgkin's lymphoma. Mayo's lymphoma group is one of the largest and most experienced in the U.S., treating more than 8,000 patients each year at Mayo's campuses in Arizona, Florida and Minnesota.
Mayo Clinic is also a leader in lymphoma research. The National Cancer Institute (NCI) has designated Mayo Clinic a comprehensive cancer center and helps fund Mayo's lymphoma research through a Lymphoma SPORE Grant (Specialized Program of Research Excellence). Mayo applies that research to developing more effective and less toxic treatments for all forms of lymphoma. Mayo Clinic conducts many clinical trials to test new therapies for the disease.
At Mayo Clinic, specialists from hematology, radiation oncology, nuclear medicine, dermatology, pediatrics and other specialties work together to treat lymphoma. Mayo's integrated group practice gives patients rapid access to the expertise needed to treat their condition.
Lymphoma is a cancer of the lymphatic system, the body's disease-fighting network. The lymphatic system includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect all those areas as well as other organs throughout the body.
Learn more about diagnosis and treatment of specific lymphomas at Mayo Clinic:
Non-Hodgkin's lymphoma, including:
Hodgkin's lymphoma (also called Hodgkin's disease)
See all news.